Current and prospective sights in mechanism of deoxynivalenol‐induced emesis for future scientific study and clinical treatment

Deoxynivalenol (DON), one of trichothecene mycotoxins produced by the fungus Fusarium, is commonly detected in cereal foods and in secondary food production across the world. Lower concentrations of DON induce a dose‐related feed refusal (anorexia), whereas it acts as a potent emetic agent at higher levels. DON‐induced emesis in humans and livestock can be observed and recorded in both undeveloped and developed regions such as Lixian, Guide and Huangzhong in China and Illinois in the USA. Some studies with different animal models (pigs and minks) suggested that DON could change expressions of 5‐hydroxytryptamine, peptide YY, neuropeptide Y2 receptor and nucleobindin‐2/nesfatin‐1 in plasma and different areas of the brain. Some selective antagonist of 5‐hydroxytryptamine 3 receptors can inhibit DON‐induced emetic response. Otherwise, the Ca2+ homeostasis and MAPK pathway could be potential directions in future studies. Dolasetron, dantrolene and JNJ‐31020028 can be used in clinical treatment but they have potential toxic effects. (−)Epicatechin, ginger phytochemicals and isoflavone can be tested in in vitro and in vivo for their usage as food additives for reducing the emesis. The present review summarizes and discusses some information from previous and recent prominent publications with the aim to provide some comprehensive and helpful data for understanding the mechanism of DON‐induced emesis. Copyright © 2017 John Wiley & Sons, Ltd.

[1]  W. Fischle,et al.  Oxidative stress signaling to chromatin in health and disease , 2016, Epigenomics.

[2]  Xiong Guo,et al.  Prevalence of Selenium, T-2 Toxin, and Deoxynivalenol in Kashin–Beck Disease Areas in Qinghai Province, Northwest China , 2016, Biological Trace Element Research.

[3]  S. Chebolu,et al.  Thapsigargin-induced activation of Ca2+-CaMKII-ERK in brainstem contributes to substance P release and induction of emesis in the least shrew , 2016, Neuropharmacology.

[4]  B. Félix,et al.  Dysregulation of energy balance by trichothecene mycotoxins: Mechanisms and prospects. , 2015, Neurotoxicology.

[5]  D. Moher,et al.  Comparative safety of serotonin (5-HT3) receptor antagonists in patients undergoing surgery: a systematic review and network meta-analysis , 2015, BMC Medicine.

[6]  Tarun E. Hutchinson,et al.  L‐Type Calcium Channels Contribute to 5‐HT3‐Receptor‐Evoked CaMKIIα and ERK Activation and Induction of Emesis in the Least Shrew (Cryptotis parva) , 2015, European journal of pharmacology.

[7]  S. Bursian,et al.  Comparison of anorectic and emetic potencies of deoxynivalenol (vomitoxin) to the plant metabolite deoxynivalenol-3-glucoside and synthetic deoxynivalenol derivatives EN139528 and EN139544. , 2014, Toxicological sciences : an official journal of the Society of Toxicology.

[8]  J. Zentek,et al.  Mechanisms underlying the inhibitory effect of the feed contaminant deoxynivalenol on glucose absorption in broiler chickens. , 2014, Veterinary journal.

[9]  Tarun E. Hutchinson,et al.  Serotonin 5-HT3 Receptor-Mediated Vomiting Occurs via the Activation of Ca2+/CaMKII-Dependent ERK1/2 Signaling in the Least Shrew (Cryptotis parva) , 2014, PloS one.

[10]  H. Stopper,et al.  Signaling steps in the induction of genomic damage by insulin in colon and kidney cells. , 2014, Free radical biology & medicine.

[11]  W. Bao,et al.  Deoxynivalenol induced oxidative stress and genotoxicity in human peripheral blood lymphocytes. , 2014, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[12]  J. Rudd,et al.  Looking beyond 5-HT(3) receptors: a review of the wider role of serotonin in the pharmacology of nausea and vomiting. , 2014, European journal of pharmacology.

[13]  T. Alkam,et al.  Broad-spectrum antiemetic potential of the L-type calcium channel antagonist nifedipine and evidence for its additive antiemetic interaction with the 5-HT(3) receptor antagonist palonosetron in the least shrew (Cryptotis parva). , 2014, European journal of pharmacology.

[14]  I. Sahin,et al.  Ghrelins, obestatin, nesfatin-1 and leptin levels in pregnant women with and without hyperemesis gravidarum. , 2013, Clinical biochemistry.

[15]  S. Bursian,et al.  Peptide YY3-36 and 5-hydroxytryptamine mediate emesis induction by trichothecene deoxynivalenol (vomitoxin). , 2013, Toxicological sciences : an official journal of the Society of Toxicology.

[16]  A. McCarthy,et al.  Ginger (Zingiber officinale) and chemotherapy-induced nausea and vomiting: a systematic literature review. , 2013, Nutrition reviews.

[17]  J. Pestka,et al.  Anorexia induction by the trichothecene deoxynivalenol (vomitoxin) is mediated by the release of the gut satiety hormone peptide YY. , 2012, Toxicological sciences : an official journal of the Society of Toxicology.

[18]  A. Czarnecka,et al.  Novel clinical applications of dual energy computed tomography. , 2012, Advances in clinical and experimental medicine : official organ Wroclaw Medical University.

[19]  L. Mounien,et al.  Advances in Deoxynivalenol Toxicity Mechanisms: The Brain as a Target , 2012, Toxins.

[20]  S. Dalesman,et al.  A flavonol present in cocoa [(−)epicatechin] enhances snail memory , 2012, Journal of Experimental Biology.

[21]  M. Baliga,et al.  Zingiber officinale (ginger) as an anti-emetic in cancer chemotherapy: a review. , 2012, Journal of alternative and complementary medicine.

[22]  T. Alkam,et al.  Synergistic antiemetic interactions between serotonergic 5-HT3 and tachykininergic NK1-receptor antagonists in the least shrew (Cryptotis parva) , 2011, Pharmacology Biochemistry and Behavior.

[23]  T. Giordano,et al.  Cav1.2 L-Type Ca2+ Channels Mediate Cocaine-Induced GluA1 Trafficking in the Nucleus Accumbens, a Long-Term Adaptation Dependent on Ventral Tegmental Area Cav1.3 Channels , 2011, The Journal of Neuroscience.

[24]  S. Yamawaki,et al.  Protective Action of Neurotrophic Factors and Estrogen against Oxidative Stress-Mediated Neurodegeneration , 2011, Journal of toxicology.

[25]  R. Donahue,et al.  Tonic inhibition of chronic pain by neuropeptide Y , 2011, Proceedings of the National Academy of Sciences.

[26]  D. Biswas,et al.  Moringa oleifera induced potentiation of serotonin release by 5-HT(3) receptors in experimental ulcer model. , 2011, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[27]  J. Pestka.  Deoxynivalenol: mechanisms of action, human exposure, and toxicological relevance , 2010, Archives of Toxicology.

[28]  Dr David Vauzour,et al.  Flavonoids and cognition: the molecular mechanisms underlying their behavioural effects. , 2009, Archives of biochemistry and biophysics.

[29]  Andrew P. Ray,et al.  Evidence for a re-evaluation of the neurochemical and anatomical bases of chemotherapy-induced vomiting. , 2009, Chemical reviews.

[30]  Andrew P. Ray,et al.  Ablation of least shrew central neurokinin NK1 receptors reduces GR73632-induced vomiting. , 2009, Behavioral neuroscience.

[31]  Seok-Jin R. Lee,et al.  Activation of CaMKII in single dendritic spines during long-term potentiation , 2009, Nature.

[32]  K. Inoue,et al.  Peripheral administration of nesfatin-1 reduces food intake in mice: the leptin-independent mechanism. , 2009, Endocrinology.

[33]  Jason U Tilan,et al.  Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome , 2007, Nature Medicine.

[34]  S. Doubova,et al.  Effect of a Psidii guajavae folium extract in the treatment of primary dysmenorrhea: a randomized clinical trial. , 2007, Journal of ethnopharmacology.

[35]  M. Mori,et al.  Identification of nesfatin-1 as a satiety molecule in the hypothalamus , 2006, Nature.

[36]  A. DeLeon.  Palonosetron (Aloxi): a second-generation 5-HT₃ receptor antagonist for chemotherapy-induced nausea and vomiting. , 2006 .

[37]  A. Thompson,et al.  5-HT3 receptors. , 2006, Current pharmaceutical design.

[38]  C. C. Horn,et al.  Signals for nausea and emesis: Implications for models of upper gastrointestinal diseases , 2006, Autonomic Neuroscience.

[39]  L. Edvinsson,et al.  Neurobiology in primary headaches , 2005, Brain Research Reviews.

[40]  Alan D. Woolf,et al.  Calcium Channel Blocker Ingestion: An Evidence-Based Consensus Guideline for Out-of-Hospital Management , 2005, Clinical toxicology.

[41]  K. Setchell,et al.  Dietary isoflavones alter regulatory behaviors, metabolic hormones and neuroendocrine function in Long-Evans male rats , 2004, Nutrition and Metabolism.

[42]  F. Wappler,et al.  Dantrolene – A review of its pharmacology, therapeutic use and new developments , 2004, Anaesthesia.

[43]  C. Wild,et al.  Development of a urinary biomarker of human exposure to deoxynivalenol. , 2003, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[44]  C. Sternini,et al.  Expression of 5-HT3 receptors in the rat gastrointestinal tract. , 2002, Gastroenterology.

[45]  D. Surmeier,et al.  Stimulation of 5-HT(2) receptors in prefrontal pyramidal neurons inhibits Ca(v)1.2 L type Ca(2+) currents via a PLCbeta/IP3/calcineurin signaling cascade. , 2002, Journal of neurophysiology.

[46]  P J Hornby,et al.  Central neurocircuitry associated with emesis. , 2001, The American journal of medicine.

[47]  R. Mook,et al.  Antiviral action & tissue uptake of AZT-sterol dicarboxylates. , 1998, Biochemical Society transactions.

[48]  P. Rondé,et al.  High Calcium Permeability of Serotonin 5‐HT3 Receptors on Presynaptic Nerve Terminals from Rat Striatum , 1998, Journal of neurochemistry.

[49]  D. Prelusky.  The effect of deoxynivalenol on serotoninergic neurotransmitter levels in pig blood. , 1994, Journal of environmental science and health. Part. B, Pesticides, food contaminants, and agricultural wastes.

[50]  H. Trenholm,et al.  The efficacy of various classes of anti-emetics in preventing deoxynivalenol-induced vomiting in swine. , 1993, Natural toxins.

[51]  P. Andrews,et al.  Diarrhoea as a side effect of digoxin. , 1990, BMJ.

[52]  Gavin Kilpatrick,et al.  5‐HT3 receptors , 1990, Medicinal research reviews.

[53]  J. Kucharczyk,et al.  Regulatory peptides and the onset of nausea and vomiting. , 1990, Canadian journal of physiology and pharmacology.

[54]  R. Harding,et al.  Identification and characterization of the emetic effects of peptide YY , 1989, Peptides.

[55]  R. Leslie,et al.  Autoradiographic localization of peptide YY and neuropeptide Y binding sites in the medulla oblongata , 1988, Peptides.

[56]  B. Costall,et al.  Antiemetic properties of the 5HT3-receptor antagonist, GR38032F. , 1987, Cancer treatment reviews.

[57]  J. Pestka,et al.  Emetic activity of the trichothecene 15-acetyldeoxynivalenol in swine. , 1987, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[58]  V. Valli,et al.  Vomitoxin in corn fed to young pigs. , 1983, Journal of animal science.

[59]  P. Hamilton,et al.  Acute toxicity of vomitoxin (Deoxynivalenol) in broiler chickens. , 1981, Poultry science.

[60]  J. Tuite,et al.  Emetic and refusal activity of deoxynivalenol to swine , 1977, Applied and environmental microbiology.

[61]  A. Ciegler,et al.  Isolation of the emetic principle from Fusarium-infected corn. , 1973, Applied microbiology.

[62]  G. Sanger,et al.  Ghrelin and motilin receptors as drug targets for gastrointestinal disorders , 2016, Nature Reviews Gastroenterology &Hepatology.

[63]  A. Jean,et al.  c-Fos immunoreactivity in the pig brain following deoxynivalenol intoxication: focus on NUCB2/nesfatin-1 expressing neurons. , 2013, Neurotoxicology.

[64]  S. Bursian,et al.  Comparison of emetic potencies of the 8-ketotrichothecenes deoxynivalenol, 15-acetyldeoxynivalenol, 3-acetyldeoxynivalenol, fusarenon X, and nivalenol. , 2013, Toxicological sciences : an official journal of the Society of Toxicology.

[65]  A. Billio,et al.  Serotonin receptor antagonists for highly emetogenic chemotherapy in adults. , 2010, The Cochrane database of systematic reviews.

[66]  G. Wakabayashi,et al.  Soluble Fas and soluble Fas L levels in patients with acute pancreatitis. , 2000, Research communications in molecular pathology and pharmacology.

[67]  H. Trenholm,et al.  Effect of deoxynivalenol on neurotransmitters in discrete regions of swine brain , 1992, Archives of environmental contamination and toxicology.

[68]  D. Acosta,et al.  Comparison of dantrolene sodium with erythromycin estolate using primary cultures of rat hepatocytes. , 1985, Drug and chemical toxicology.